Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adventa BhdXKLS:7191 32 3-Year Share Buyback Ratio is -19.70 as of Jun. 2026. GuruFocus rates XKLS:7191 with a GF Score™ of 32/100 and a GF Value™ of RM0.17 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 615 Medical Devices & Instruments companies, Adventa Bhd ranks worse than 78.54% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Adventa Bhd's current 3-Year Share Buyback Ratio was -19.70%.
The historical rank and industry rank for Adventa Bhd's 3-Year Share Buyback Ratio or its related term are showing as below:
XKLS:7191'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -19.7 Med: 0 Max: 31.4
Current: -19.7
During the past 13 years, Adventa Bhd's highest 3-Year Share Buyback Ratio was 31.40%. The lowest was -19.70%. And the median was 0.00%.
XKLS:7191's 3-Year Share Buyback Ratio is ranked worse than 78.54% of 615
companies
in the Medical Devices & Instruments industry
Industry Median: -2.6
vs XKLS:7191: -19.70
Adventa Bhd (XKLS:7191) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Adventa Bhd 3-Year Share Buyback Ratio Related Terms
XKLS:7191 vs ISRG, BDX, RMD: 3-Year Share Buyback Ratio Comparison
For the Medical Instruments & Supplies subindustry, Adventa Bhd's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adventa Bhd 3-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Adventa Bhd's 3-Year Share Buyback Ratio falls into.
Adventa Bhd 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -19.70 mean?
Adventa Bhd (XKLS:7191) has a 3-Year Share Buyback Ratio of -19.70 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Adventa Bhd and its competitors. According to the industry distribution chart, Adventa Bhd ranks #483 out of 615 companies in the Medical Devices & Instruments industry, placing it in the top 78.5%.
Is Adventa Bhd's 3-Year Share Buyback Ratio too high?
Adventa Bhd's current 3-Year Share Buyback Ratio is -19.70. Based on the distribution chart, Adventa Bhd ranks #483 out of 615 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Adventa Bhd has a GF Score™ of 32/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's 3-Year Share Buyback Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #483 out of 615 companies for 3-Year Share Buyback Ratio. This places Adventa Bhd in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Adventa Bhd and its competitors. Adventa Bhd's current 3-Year Share Buyback Ratio is -19.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.17, compared to a current price of RM0.13 — trading 23.5% below its estimated fair value. The current 3-Year Share Buyback Ratio is -19.70. Adventa Bhd's overall GF Score™ is 32/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current 3-Year Share Buyback Ratio is -19.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adventa Bhd (XKLS:7191) Overvalued in 2026?
Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued.
The current stock price of RM0.13 is trading 23.5% below its estimated GF Value™ of RM0.17.
GuruFocus considers Adventa Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7191:
3-Year Share Buyback Ratio: -19.70
GF Value™: RM0.17 vs. price of RM0.13 (23.5% below fair value)
No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
32GF Score
Get the complete analysis for XKLS:7191
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7191 has been successfully added to your 
